Targeted therapies for patients with germ cell tumors
- 25 March 2008
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 17 (4) , 511-522
- https://doi.org/10.1517/13543784.17.4.511
Abstract
(2008). Targeted therapies for patients with germ cell tumors. Expert Opinion on Investigational Drugs: Vol. 17, No. 4, pp. 511-522. doi: 10.1517/13543784.17.4.511Keywords
This publication has 101 references indexed in Scilit:
- Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North AmericaNew England Journal of Medicine, 2007
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaNew England Journal of Medicine, 2006
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Testicular germ-cell tumours in a broader perspectiveNature Reviews Cancer, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumorsOncogene, 2002
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998